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Electrocardiography (FIGURE 1B) showed no signs 
typical of HCM (according to the European Soci‑
ety of Cardiology guidelines).1 On two 24 ‑hour 
Holter examinations, 3 consecutive ventricular 
beats were recorded (a short episode of nonsus‑
tained ventricular tachycardia with a heart rate 
of 138 bpm). No sudden death was reported in 
family history. To improve the quality of imag‑
ing, we used cardiac magnetic resonance (CMR) 
imaging with gadolinium contrast. It demon‑
strated left ventricular hypertrophy suggestive 
of HCM: diastolic maximum wall thickness in 
the inferior wall of 15 mm and late gadolinium 
hyperenhancement in the segment with maxi‑
mum thickness (FIGURE 1C and 1D). Left ventricu‑
lar ejection fraction calculated from high ‑quality 
CMR images was normal (79%). On a treadmill 
exercise test, the patient achieved a workload of 
7 metabolic equivalents at a maximum heart rate 
of 86%. Maximum oxygen uptake was normal 
(96% of the predicted value). The test was ter‑
minated due to fatigue. The asymptomatic sta‑
tus corresponded with normal results of exercise 
Hypertrophic cardiomyopathy (HCM) is a com‑
mon genetic cardiac disease with a diverse clin‑
ical phenotype and imaging results; therefore, 
genotyping is of key importance in establishing 
a proper diagnosis.1 To illustrate these diagnos‑
tic challenges, we report a case of a 61 ‑year ‑old 
woman referred for family (including genetic) 
screening after diagnosing her daughter with 
a fully developed phenotype of HCM and typical 
echocardiographic findings at the age of 30 years. 
An MYBPC3 c.2541 C>G, p.(Tyr847*) mutation 
in the myosin ‑binding protein C gene was detect‑
ed in the proband (FIGURE 1A).
The MYBPC3 p.Tyr847* mutation was discov‑
ered in 2004. In the ClinVar database, it has been 
reported several times in HCM patients from dif‑
ferent countries as pathogenic or likely pathogen‑
ic. In the mother of the proband, echocardiog‑
raphy failed to show typical abnormalities, part‑
ly due to problems with proper visualization and 
measurements (the maximum wall thickness was 
about 12–13 mm without left ventricular outflow 
tract obstruction). The patient was asymptomatic. 
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FIGURE 1 Examinations in a patient suspected of hypertrophic cardiomyopathy: A – direct sequencing of gene encoding
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test (96% of the predicted value of maximum 
oxygen uptake).
The relevance of CMR and exercise testing in 
a differential diagnosis of HCM was reported 
previously.2 CMR imaging is helpful in 20% of 
HCM patients in whom echocardiography is in‑
conclusive, especially when showing borderline 
left ventricular hypertrophy.3 CMR imaging al‑
lows also a visualization of pathological late gad‑
olinium enhancement (potential arrhythmogen‑
ic substrate).4 To our knowledge, only one paper 
reported the use of CMR imaging in a single pa‑
tient with this mutation, but no typical features 
of the late gadolinium hyperenhancement pat‑
tern were described.5 In conclusion, CMR imag‑
ing may be helpful when diagnosis is uncertain, 
for example, when the proband’s mother is sus‑
pected of HCM and HCM is confirmed in the pro‑
band using genetic testing. However, this case 
shows that genotyping should be performed in 
case of inconclusive imaging findings.
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FIGURE 1 Examinations 
in a patient suspected of 
hypertrophic 
cardiomyopathy (HCM): 
B – electrocardiograms 
showing no signs typical 
of HCM; C – cardiac 
magnetic resonance 
(CMR) image: 
hypertrophied myocardial 
segment with late 
gadolinium enhancement 
(arrow; long -axis view); 
D – CMR image: 
hypertrophied myocardial 
segment with late 
gadolinium enhancement 
(arrow; short axis -view)
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